Mass spectrometry-based biomarker discovery: Toward a global proteome index of individuality

Annual Review of Analytical Chemistry

Volumn 2, Issue , 2009, Pages 265-277

  Hawkridge, Adam M ^a   Muddiman, David C ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

Analytical variability; Biological variability; Longitudinal sampling

Indexed keywords

BIOLOGICAL MARKER; PROTEOME;

ANIMAL; ARTICLE; HUMAN; INSTRUMENTATION; MASS SPECTROMETRY; METHODOLOGY; PROTEOMICS; DEVICES; PROCEDURES;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS;

EID: 70349759769     PISSN: 19361327     EISSN: 19361335     Source Type: Book Series    
DOI: 10.1146/annurev.anchem.1.031207.112942     Document Type: Article

References (62)

1. Atkinson AJ, Colburn C, DeGruttola D, Demets D, Downing D, et al. 2001. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin. Pharmacol. Ther. 69:89-95
2. Elin R.J. 1980. Instrumentation in clinical chemistry. Science 210:286-89
3. Chace D.H. 2001. Mass spectrometry in the clinical laboratory. Chem. Rev. 101:445-77
4. McPherson RA, Pincus MR, eds. 2007. Henry's Clinical Diagnosis and Management by Laboratory Methods. Philadelphia: Saunders Elsevier. 1450 pp. 21st ed.
5. Burtis CA, Ashwood A, eds. 1996. Tietz Fundamentals of Clinical Chemistry. Philadelphia: W. B. Saunders. 881 pp. 4th ed.
6. Anderson NL, Anderson N.G. 2002. The human plasma proteome-history, character, and diagnostic prospects. Mol. Cell. Proteomics 1:845-67
7. Ransohoff D.F. 2005. Opinion-bias as a threat to the validity of cancer molecular-marker research. Nat. Rev. Cancer 5:142-49
8. Master S.R. 2005. Diagnostic proteomics: back to basics? Clin. Chem. 51:1333-34
9. Check E. 2004. Proteomics and cancer-running before we can walk? Nature 429:496-97
10. Diamandis E.P. 2004. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol. Cell. Proteomics 3:367-78
11. Hortin G.L. 2005. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin. Chem. 51:3-5
12. Lundblad R.L. 2006. The Evolution from Protein Chemistry to Proteomics: Basic Science to Clinical Application. Boca Raton: CRC. 295 pp.
13. Ransohoff D.F. 2004. Opinion-rules of evidence for cancer molecular-marker discovery and validation. Nat. Rev. Cancer 4:309-14
14. Fenn JB, Mann M, Meng M, Wong W, Whitehouse C.M. 1989. Electrospray ionization for mass-spectrometry of large biomolecules. Science 246:64-71
15. Karas M, Hillenkamp F. 1988. Laser desorption ionization of proteins with molecular masses exceeding 10, 000 daltons. Anal. Chem. 60:2299-301
16. Tomer K.B. 2001. Separations combined with mass spectrometry. Chem. Rev. 101:297-328
17. Wasinger VC, Cordwell C, Cerpa-Poljak A, Yan JX, Gooley AA, et al. 1995. Progress with gene-product mapping of the mollicutes-Mycoplasma genitalium. Electrophoresis 16:1090-94
18. Taylor J, Anderson A, Scandora Jr S, Willard KE, Anderson N.G. 1982. Design and implementation of a prototype Human Protein Index. Clin. Chem. 28:861-66
19. Anderson L. 2005. Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J. Physiol. 563:23-60
20. Maisel AS, Bhalla V, Braunwald E. 2006. Cardiac biomarkers: a contemporary status report. Nat. Clin. Pract. Cardiovasc. Med. 3:24-34
21. Berhane BT, Zong Z, Liem L, Huang A, Le S, et al. 2005. Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 5:3520-30
22. Wulfkuhle JD, Liotta LA, Petricoin E.F. 2003. Proteomic applications for the early detection of cancer. Nat. Rev. Cancer 3:267-75
23. Keesee S.K. 2002. Molecular diagnostics: impact upon cancer detection. Expert Rev. Mol. Diagn. 2:91-92
24. Hondermarck H. 2003. Breast cancer: when proteomics challenges biological complexity. Mol. Cell. Proteomics 2:281-91
25. Hondermarck H, Vercoutter-Edouart AS, Rev́illion F, Lemoine J, el-Yazidi-Belkoura I, et al. 2001. Proteomics of breast cancer for marker discovery and signal pathway profiling. Proteomics 1:1216-32
26. Wulfkuhle JD, McLean M, Paweletz P, Sgroi S, Trock T, et al. 2001. New approaches to proteomic analysis of breast cancer. Proteomics 1:1205-15
27. Ardekani AM, Liotta L, Petricoin P 3rd. 2002. Clinical potential of proteomics in the diagnosis of ovarian cancer. Expert Rev. Mol. Diagn. 2:312-20 (Pubitemid 34764481)
28. Lee CJ, Ariztia EV, Fishman D.A. 2007. Conventional and proteomic technologies for the detection of early stage malignancies: markers for ovarian cancer. Crit. Rev. Clin. Lab. Sci. 44:87-114
29. Posadas EM, Davidson B, Kohn E.C. 2004. Proteomics and ovarian cancer: implications for diagnosis and treatment: a critical review of the recent literature. Curr. Opin. Oncol. 16:478-84
30. Williams TI, Toups T, Saggese S, Kalli K, Cliby C, Muddiman D.C. 2007. Epithelial ovarian cancer: disease etiology, treatment, detection, and investigational gene, metabolite, and protein biomarkers. J. Proteome Res. 6:2936-62
31. Valle RP, Chavany C, Zhukov TA, Jendoubi M. 2003. New approaches for biomarker discovery in lung cancer. Expert Rev. Mol. Diagn. 3:55-67
32. Davidsson P, Sjogren M. 2005. The use of proteomics in biomarker discovery in neurodegenerative diseases. Dis. Markers 21:81-92
33. Dunckley T, Coon KD, Stephan D.A. 2005. Discovery and development of biomarkers of neurological disease. Drug Dis. Today 10:326-34
34. Hortin GL, Jortani J, Ritchie R, Valdes Jr V, Chan D.W. 2006. Proteomics: a new diagnostic frontier. Clin. Chem. 52:1218-22
35. Jacobs IJ, Menon U. 2004. Progress and challenges in screening for early detection of ovarian cancer. Mol. Cell. Proteomics 3:355-66
36. Molloy MP, Brzezinski B, Hang H, McDowell M, Van Bogelen V. 2003. Overcoming technical variation and biological variation in quantitative proteomics. Proteomics 3:1912-19
37. Semmes O.J. 2005. The "omics" haystack: defining sources of sample bias in expression profiling. Clin. Chem. 51:1571-72
38. Muddiman D.C. 2006. "Lewis and Clark" proteomics. J. Proteome Res. 5:221-22
39. Zhang W, Czernik AJ, Yungwirth T, Aebersold R, Chait B.T. 1994. Matrix-assisted laser desorption mass spectrometric peptide mapping of proteins separated by two-dimensional gel electrophoresis: determination of phosphorylation in synapsin I. Protein Sci. 3:677-86
40. Wilm M, Shevchenko A, Houthaeve T, Breit S, Schweigerer L, et al. 1996. Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry. Nature 379:466-69
41. Washburn MP, Wolters D, Yates Y 3rd. 2001. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19:242-47 (Pubitemid 32220565)
42. Loo JA, Edmonds CG, Smith R.D. 1990. Primary sequence information from intact proteins by electro-spray ionization tandem mass spectrometry. Science 248:201-4
43. Henry KD, Williams W, Wang W, McLafferty M, Shabanowitz J, Hunt D.F. 1989. Fourier-transform mass spectrometry of large molecules by electrospray ionization. Proc. Natl. Acad. Sci. USA 86:9075-78
44. Kelleher N.L. 2004. Top-down proteomics. Anal. Chem. 76:197-203A
45. Vitzthum F, Behrens F, Anderson NL, Shaw J.H. 2005. Proteomics: from basic research to diagnostic application. A review of requirements and needs. J. Proteome Res. 4:1086-97
46. Richardson R.W. 1994. Handbook of Nonpathologic Variations in Human Blood Constituents. Boca Raton, FL: CRC. 343 pp.
47. Martin HF, Guzinowicz BJ, Fanger H. 1975. Normal Values in Clinical Chemistry: A Guide to Statistical Analysis of Laboratory Data, Vol. 1. New York: Marcel Dekker. 503 pp.
48. Harris EK, Boyd J.C. 1995. Statistical Bases of Reference Values in Laboratory Medicine, Vol. 146. New York: Marcel Dekker. 361 pp.
49. Williams R.J. 1956. Biochemical Individuality: The Basis for the Genetotrophic Concept. New York: Wiley. 214 pp.
50. Schneider A.J. 1960. Some thoughts on normal, or standard, values in clinical medicine. Pediatrics 26:973-84
51. Keating FR, Jones J, Elveback E, Randall R.V. 1969. Relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin and blood urea. J. Lab. Clin. Med. 73:825-34
52. Cotlove E, Harris EK, Williams G.Z. 1970. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 3. Physiological and medical implications. Clin. Chem. 16:1028-32
53. Harris EK, Kanofsky P, Shakarji G, Cotlove E. 1970. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 2. Estimating biological components of variation. Clin. Chem. 16:1022-27
54. Williams GZ, Young Y, Stein S, Cotlove E. 1970. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 1. Objectives, subject selection, laboratory procedures, and estimation of analytic deviation. Clin. Chem. 16:1016-21
55. Harris EK, Demets D.L. 1971. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 5. Estimated biological variations in ionized calcium. Clin. Chem. 17:983-87
56. Young DS, Harris EK, Cotlove E. 1971. Biological and analytic components of variation in long-term studies of serum constituents in normal subjects. 4. Results of a study design to eliminate long-term analytic deviations. Clin. Chem. 17:403-10
57. Harris EK, Demets D.L. 1972. Effects of intra-individual and inter-individual variation on distributions of single measurements. Clin. Chem. 18:244-49
58. Harris E.K. 1974. Effects of intraindividual and interindividual variation on appropriate use of normal ranges. Clin. Chem. 20:1535-42
59. Harris E.K. 1975. Some theory of reference values. 1. Stratified (categorized) normal ranges and a method for following an individual's clinical laboratory values. Clin. Chem. 21:1457-64
60. Harris E.K. 1976. Some theory of reference values. 2. Comparison of some statistical models of intraindi-vidual variation in blood constituents. Clin. Chem. 22:1343-50
61. Harris EK, Cooil BK, Shakarji G, Williams G.Z. 1980. On the use of statistical models of within-person variation in long-term studies of healthy individuals. Clin. Chem. 26:383-91
62. Fawcett JK, Wynn V. 1960. Effects of posture on plasma volume and some blood constituents. J. Clin. Pathol. 13:304-10